Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte

Journal of Experimental Medicine

Volumn 189, Issue 10, 1999, Pages 1555-1564

  Guidotti, Luca G ^a   Borrow, Persephone ^a,b   Brown, Amy ^a   McClary, Heike ^a   Koch, Rick ^a   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

Cytokines; Hepatocyte; Lymphocytic choriomeningitis virus; Noncytopathic clearance

Indexed keywords

BETA GALACTOSIDASE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; LYMPHOTOXIN; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CLEARANCE; CONTROLLED STUDY; HEPATITIS B VIRUS; LIVER CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VIRUS INACTIVATION;

ADENOVIRIDAE; ALANINE TRANSAMINASE; ANIMALS; ANTIGENS, CD; CYTOKINES; GENE EXPRESSION; INTERFERONS; INTERLEUKINS; KIDNEY TUBULES; LIVER; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA, VIRAL; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 0033577852     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.10.1555     Document Type: Article

References (31)

1. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:25-36.
2. Cavanaugh, V.J., L.G. Guidotti, and F.V. Chisari. 1997. Interleukin-12 inhibits hepatitis B virus replication in HBV transgenic mice. J. Virol. 71:3236-3243.
3. Guidotti, L.G., P. Borrow, M.V. Hobbs, B. Matzke, I. Gresser, M.B.A. Oldstone, and F.V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA. 93:4589-4594.
4. Cavanaugh, V.J., L.G. Guidotti, and F.V. Chisari. 1998. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in HBV transgenic mice. J. Virol. 72:2630-2637.
5. 4a. Guidotti, L.G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and Francis V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science. 284:825-829.
6. Borrow, P., and M.B.A. Oldstone. 1997. Lymphocytic choriomeningitis virus. In Viral Pathogenesis. N. Nathanson, editor. Lippincott-Raven Publishers, Philadelphia. 593-627.
7. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, J. Olsen, E.R. Podack, R. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369: 31-37.
8. Walsh, C.M., M. Matloubian, C.-C. Liu, R. Ueda, G.G. Kurahara, J.L. Christensen, M.T. Huang, J.D.-E. Young, R. Ahmed, and W.R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA. 91: 10854-10858.
9. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
10. Leist, T.P., M. Eppler, and R.M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J. Virol. 63:2813-2819.
11. Wille, A., A. Gessner, H. Lother, and F. Lehmann-Grube. 1989. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Eur. J. Immunol. 19:1283-1288.
12. Moskophidis, D., M. Battegay, M.-A. Bruendler, E. Laine, I. Gresser, and R. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and gamma interferon. J. Virol. 68:1951-1955.
13. Lehmann-Grube, F., U. Assmann, C. Loliger, D. Moskophidis, and J. Lohler. 1985. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J. Immunol. 134:608-615.
14. Gegin, C., and F. Lehmann-Grube. 1992. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J. Immunol. 149:3331-3338.
15. Tishon, A., H. Lewiski, G. Rall, M. Von Herrath, and M.B.A. Oldstone. 1995. An essential role for type 1 interferon-γ in terminating persistent viral infection. Virology. 212:244-250.
16. Dutko, F.J., and M.B. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
17. Kozarsky, K., and J.M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499-503.
18. Graham, F.L., J. Smiley, W.C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
19. Engelhardt, J.F., Y. Yang, L.D. Stratford-Perricaudet, E.D. Allen, K. Kozarsky, M. Perricaudet, J.R. Yankaskas, and J.M. Wilson. 1993. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat. Genet. 4:27-34.
20. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156-159.
21. Hobbs, M.V., W.O. Weigle, D.J. Noonan, B.E. Torbett, R.J. McEvilly, R.J. Koch, G.J. Cardenas, and D.N. Ernst. 1993. Patterns of cytokine gene expression by CD4 T cells from young and old mice. J. Immunol. 150:3602-3614.
22. Guidotti, L.G., B. Matzke, H. Schaller, and F.V. Chisari. 1995. High level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
23. Southern, P.J., M.K. Singh, Y. Riviere, D.R. Jacoby, M.J. Buchmeier, and M.B. Oldstone. 1987. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology. 157:145-155.
24. Evans, C.F., P. Borrow, J.C. de la Torre, and M.B. Oldstone. 1994. Virus-induced immunosuppression: kinetic analysis of the selection of a mutation associated with viral persistence. J. Virol. 68:7367-7373.
25. Surh, C.D., E.-K. Gao, H. Kosaka, D. Lo, C. Ahn, D.B. Murphy, L. Karlsson, P. Peterson, and J. Sprent. 1992. Two subsets of epithelial cells in the thymic medulla. J. Exp. Med. 176:495-505.
26. Feutren, G., B. Lacour, and J.F. Bach. 1984. Immune lysis of hepatocytes in culture: accurate detection by aspartate aminotransferase release measurement. J. Immunol. Methods. 75: 85-94.
27. Ando, K., T. Moriyama, L.G. Guidotti, S. Wirth, R.D. Schreiber, H.J. Schlicht, S. Huang, and F.V. Chisari. 1993. Mechanisms of class 1-restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178: 1541-1554.
28. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA. 94:6874-6879.
29. Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunol. Today. 15:74-80.
30. Guidotti, L.G., and F.V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8:478-483.
31. Tay, C.H., and R.M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267-275.